European Urology Focus

Article	Citations
Survival of Patients with Chronic Kidney Disease Treated with Radical Cystectomy and Risk Factors of Glomerular Filtration Rate Loss Following Radical Cystectomy: Two Systematic Reviews and Meta-analy	190
Editorial Board	190
Corrigendum to “A systematic review and meta-analysis on the impact of infertility on men’s general health” [Eur. Urol. Focus (2023) 10(1):98–106.]	88
Data Mining in Urology: Understanding Real-world Treatment Pathways for Lower Urinary Tract Systems via Exploration of Big Data	83
Reply to: Francesco Montorsi, Francesco Montorsi, Giuseppe Rosiello, Marco Moschini, Andrea Salonia, and Alberto Briganti’s letter to the Editor re: Akihiro Matsukawa, Takafumi Yanagisawa, Marcin Misz	79
Reply to Carmen Gravina, Riccardo Lombardo, and Cosimo De Nunzio’s Letter to the Editor re: Yash S. Khandwala, Simon John Christoph Soerensen, Shravan Morisetty, et al. The Association of Tissue Chang	78
Re: Roselyne Choinière, Philippe D. Violette, Mélanie Morin, et al. Evaluation of Benefits and Harms of Surgical Treatments for Post–radical Prostatectomy Urinary Incontinence: A Systematic Review and	68
Data Availability Statements and Data Sharing in Urology: A False Promise?	67
The Power of Hashtags in Social Media: Lessons Learnt from the Urology Tag Ontology Project	65
Interleukins in Urine and Blood as Markers of Infection and as Risk Factors for Systemic Conditions	64
Does MOSES Technology Enhance the Efficiency and Outcomes of Standard Holmium Laser Enucleation of the Prostate? Results of a Systematic Review and Meta-analysis of Comparative Studies	63
Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade N	59
Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial Carcinoma	59
Treatment Success After Urethroplasty: The Ongoing Quest for a Pragmatic and Universal Definition	58
Integrating Prehabilitation into the Cancer Survivorship Framework	56
Prehabilitation in Urology: Trial Update	52
The Role of Salvage Cystectomy After Prior Trimodality Therapy: A Multinational Match-paired Analysis	52
Radical Transurethral Resection of Bladder Tumor in Organ-confined Muscle-invasive Bladder Cancer: Yes!	52
Is Engineered Tissue the Future of Bladder Reconstruction: Con	52
Oncologic Outcome of the Extent of Pelvic Lymph Node Dissection During Radical Prostatectomy: A Systematic Review, Meta-analysis, and Network Analysis	51
Editorial Board	50
Prostate-specific Membrane Antigen Biology in Lethal Prostate Cancer and its Therapeutic Implications	49
Contents	48
Predictors of Poor Response and Adverse Events Following Botulinum Toxin A for Refractory Idiopathic Overactive Bladder: A Systematic Review	48
Re: Luis Alberto Dorantes-Carrillo, Mario Basulto-Martínez, Rodrigo Suárez-Ibarrola, et al. Retrograde Intrarenal Surgery Versus Miniaturized Percutaneous Nephrolithotomy for Kidney Stones >1 cm: A	48

Editorial Board	48
A Contemporary Case Series of Complex Surgical Repair of Surgical/Endoscopic Injuries to the Abdominal Ureter	48
Evidence based Urology: The Gist Leading Us to the Evidence for Decisions	47
Artificial INtelligence to Support Informed DEcision-making (INSIDE) for Improved Literature Analysis in Oncology	47
Anxiety and Health-related Quality of Life in Men with Prostate Cancer Undergoing Focal Therapy: A Prospective Single-arm Phase 2 Trial	46
Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care: Findings from the PriMUS Study	46
Contents	46
Radioguided Surgery for Prostate Cancer	44
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatecto	42
Percutaneous Ablation Versus Surgical Resection for Local Recurrence Following Partial Nephrectomy for Renal Cell Cancer: A Propensity Score Analysis (REPART Study—UroCCR 71)	42
Robot-assisted Implantation of an Artificial Urinary Sphincter for Females with Stress Urinary Incontinence: State of the Art and Future Perspectives	42
Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian Centers	41
International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma	41
A Systematic Review of the Efficacy and Safety of Outpatient Bladder Tumour Ablation	40
Risks of Dementia After Treatment with an Anticholinergic, Beta-3 Agonist, or Combination of Both for an Overactive Bladder: A Korean National Cohort Study	40
How to Compose Platform Trials	35
Laser Ablation Efficiency, Laser Ablation Speed, and Laser Energy Consumption During Lithotripsy: What Are They and How Are They Defined? A Systematic Review and Proposal for a Standardized Terminolog	35
Long-term Relapse and Survival in Clinical Stage I Testicular Teratoma	35
KIM-1 as a Prognostic Marker in Renal Cell Carcinoma	35
Successful Treatment of Vesicovaginal Fistulas via an Abdominal Transvesical Approach: A Single-center 50-yr Experience	35
Advances in Robotic Surgery: In Favor of the Single Port Platform	34
Editorial Board	34
On the Road Towards Curing Advanced Bladder Cancer	33
Reply to Marco Moschini, Francesco Montorsi, Andrea Salonia, Giorgio Gandaglia and Alberto Briganti’s Letter to the Editor Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethr	33
Micropapillary Versus Urothelial Carcinoma of the Urinary Bladder: Stage at Presentation and Efficacy of Chemotherapy Across All Stages—A SEER-based Study	32
Effects of a Patient Decision Aid for Nonmetastatic Prostate Cancer Established in Routine Care: The Randomized Controlled EvEnt-PCA Trial	31
Reply to Luca Sarchi, Maria Chiara Sighinolfi, Simone Assumma, et al.’s Letter to Editor re: Carlo A. Bravi, Marco Paciotti, Eleonora Balestrazzi, et al. Outcomes of Robot-assisted Radical Prostatecto	31
The Long but Necessary Journey Towards Optimization of the Cause-Effect Relationship Between Input and Output for Accountable Use of ChatGPT for Academic Purposes	31
A Multicenter Randomized Controlled Trial of Ambulatory Versus Inpatient Percutaneous Nephrolithotomy	31
Validation of a Zero-shot Learning Natural Language Processing Tool to Facilitate Data Abstraction for Urologic Research	31
Infections After Adoption of Antibiogram-directed Prophylaxis and Intracorporeal Urinary Diversion for Robot-assisted Radical Cystectomy	30
Initial Andrological Evaluation of the Infertile Male	29
Effect of Electroacupuncture Added to Pelvic Floor Muscle Training in Women with Stress Urinary Incontinence: A Randomized Clinical Trial	29
Patient Values, Preferences, and Expectations for Managing Symptoms Due to Benign Prostate Obstruction	29
The Urinary Microbiome Is a Potential Driver of Urinary Tract Pathology Through Multiple Mechanisms Including Deglucuronidation and DNA Damage	28
Re: Cameron E. Alexander, Hannah Warren, Alexander Light, et al. Ultrasound for the Diagnosis of Testicular Torsion: A Systematic Review and Meta-analysis of Diagnostic Accuracy. Eur Urol Focus. In pr	28
Effect of Levofloxacin on the Efficacy and Adverse Events in Intravesical Bacillus Calmette-Guerin Treatment for Bladder Cancer: Results of a Randomized, Prospective, Multicenter Study	28
A Systematic Review on the Impact of Quality Assurance Programs on Outcomes after Radical Prostatectomy	28
Radical Nephrectomy After Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma	27
The Impact of Telemedicine in Reducing the Carbon Footprint in Health Care: A Systematic Review and Cumulative Analysis of 68 Million Clinical Consultations	27
A Phase 2 Randomized, Placebo-controlled Crossover Trial to Evaluate Safety and Efficacy of Platelet-rich Plasma Injections for Peyronie’s Disease: Clinical Trial Update	27
Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative	26
Using Cell Lines To Guide Neoadjuvant Therapy in Bladder Cancer: COXEN and SWOG S1314	26
Contents	26
Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study	26
Editorial Board	26
Beyond Anesthesia: A Mini Review of Virtual Reality as an Adjunct in Urological Procedures	26
Overcoming the Code Duello: Achieving Long-term Cure and Optimizing Quality of Life in Testicular Cancer	25
Re: Veronika Birkhäuser, Andrea M. Sartori, Nicolas S. Bodmer, et al. Metaepidemiological Inventory of Diagnostic Studies on Urodynamics. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2019.1	25
Reply to Carmen Gravina, Riccardo Lombardo, and Cosimo De Nunzio’s Letter to the Editor re: Georges Mjaess, Alexandre Peltier, Jean-Baptiste Roche, et al. A Novel Nomogram to Identify Candidates for F	25

Diet and Health-related Quality of Life Among Men on Active Surveillance for Early-stage Prostate Cancer: The Men’s Eating and Living Study (Cancer and Leukemia Group 70807 [Alliance])	24
Decision Regret About Testicular Prosthesis After Radical Orchiectomy: Real-life Data to Improve Preoperative Patient Counseling	24
Robot-assisted Simple Prostatectomy Is Better than Endoscopic Enucleation of the Prostate	24
Benign Prostatic Hyperplasia Treatment On Its Way to Precision Medicine: Dream or Reality?	24
Re: Matthew J. Roberts, Giorgio Gandaglia, Daniela E. Oprea-Lager, et al. Pelvic Lymph Node Dissection in Prostate Cancer: Evidence and Implications. Eur Urol. In press. https://doi.org/10.1016/j.euru	24
To Stent or Not? A Pragmatic, Multicenter, Combined Randomized and Observational Clinical Trial Evaluating the Impact of Stent Omission Versus Placement After Uncomplicated Ureteroscopy	24
Short Time Delay Between Previous Prostate Biopsy for Prostate Cancer Assessment and Holmium Laser Enucleation of the Prostate Correlates with Worse Perioperative Outcomes	23
Paclitaxel-coated Balloon Dilation for Urethral Stricture Disease: 5 Years of Clinical Insights and Future Directions for Optilume	23
Placebo Response in Patients with Oral Therapy for Overactive Bladder: A Systematic Review and Meta-analysis	23
Insertion of Penile Implants in Patients with Priapism: When Is the Right Time?	23
Clinical Applications of Microbiome in Renal Cell Carcinoma	23
Re: Guru P. Sonpavde. Role of Adjuvant Therapy in Current Perioperative Immunotherapy-based Trials in Bladder Cancer: A Justified Standard. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025	23
Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre	22
Reducing the Frequency of Follow-up Cystoscopy in Low-grade pTa Non–muscle-invasive Bladder Cancer Using the ADXBLADDER Biomarker	22
Sacral Neuromodulation with the InterStim™ System for Intractable Lower Urinary Tract Dysfunctions (SOUNDS): Results of Clinical Effectiveness, Quality of Life, Patient-Reported Outcomes and Safety in	22
Outcomes of Salvage Robot-assisted Radical Prostatectomy After Focal Ablation for Prostate Cancer in Comparison to Primary Robot-assisted Radical Prostatectomy: A Matched Analysis	22
Overall Survival of Patients Receiving Cisplatin or Carboplatin for Primary Metastatic Urothelial Carcinoma of the Bladder: A Contemporary Dutch Nationwide Cohort Study	22
SATURN: A Multinational, Multicentre, Prospective Surgical Registry for Male Urinary Incontinence Surgery Across Europe with Planned 10-year Follow-up	22
Duration of Follow-up and Timing of Discharge from Imaging Follow-up, in Adult Patients with Urolithiasis After Surgical or Medical Intervention: A Systematic Review and Meta-analysis from the Europea	21
A Systematic Review and Meta-analysis on the Impact of Infertility on Men’s General Health	21
Re: Magdalena Görtz, Jan Philipp Radtke, Gencay Hatiboglu, et al. The Value of Prostate-specific Antigen Density for Prostate Imaging-Reporting and Data System 3 Lesions on Multiparametric Magnetic Re	21
Does a 55-year-old Male with Lower Urinary Tract Symptoms and a 50-ml Gland Have To Decide Between Ejaculation and Voiding Function?	21
Androgen Receptor Signaling is Similar in Human Corpus Cavernosum in Men with Different Serum Testosterone Levels	21
Re: Does MOSES Technology Enhance the Efficiency and Outcomes of Standard Holmium Laser Enucleation of the Prostate? Results of a Systematic Review and Meta-analysis of Comparative Studies	21
Treatments for Patients with Metastatic Castration-resistant Prostate Cancer Who Previously Received Triplet Therapy at the Metastatic Hormone-sensitive Stage	21
Association of Sleep Disorders with Nocturia: A Systematic Review and Nominal Group Technique Consensus on Primary Care Assessment and Treatment	20
Predicting Mirabegron Treatment Response in Patients with Overactive Bladder: A Post Hoc Analysis of Data from Clinical Trials	20
Re: Gautier Müllhaupt, Lukas Hechelhammer, Nicole Graf, et al. Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Obstruction: 5-year Outcomes of a Rando	20
Re: Salvador Arlandis. Management of Stress Urinary Incontinence in Patients with Underactive Bladder. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025.04.030	20
Treatment Patterns and Real-World Outcomes for Locally Advanced or Metastatic Urothelial Cancer in the Era of Immunotherapy	20
Adjuvant Therapy in Stage I Testicular Cancer: Surveillance for All	20
Myogenic Underactive Bladder and Heart Failure Resemblance: A Novel Role for SGLT2 Inhibition?	20
Enhancing the Immunogenicity of Nivolumab plus Ipilimumab with Live Bacterial Supplementation in Metastatic Renal Cell Carcinoma	20
Management of Impacted Ureteral Stones	20
Reply to Yun Deng, Changhong Xu, and Li Yang’s Letter to the Editor re: Vineet Gauhar, Olivier Traxer, Daniele Castellani, et al. Could Use of a Flexible and Navigable Suction Ureteral Access Sheath B	19
Discordant Endorsement of Prostate Cancer Biomarkers Across Major Guidelines	19
Challenges in Organ-sparing Surgery for Penile Cancer: What Are the Limits?	19
Managing Genital Herpes: A Mini-review for Urologists from the European Association of Urology Guidelines Panel for Urological Infections	19
Clinical Trial Protocol for PSMA-SELECT: A Dutch National Randomised Study of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as a Triage Tool for Pelvic Lymph Node	19
Thulium Fiber Versus Holmium:Yttrium-aluminum-garnet Laser for Endoscopic Enucleation of the Prostate: A Systematic Review and Meta-analysis	19
Impact of Surgery for Benign Prostatic Hyperplasia on Sexual Function: A Systematic Review and Meta-analysis of Erectile Function and Ejaculatory Function	19
Management of Primary Bladder Neck Obstruction and Dysfunctional Voiding in Young Men: A Systematic Review and Meta-analysis	19
Patients’ Trust in Artificial Intelligence–based Decision-making for Localized Prostate Cancer: Results from a Prospective Trial	19
Implications of Cardiovascular Disease for Assessment and Treatment of Nocturia in Primary Care: Systematic Review and Nominal Group Technique Consensus	19
Ferumoxtran-10-enhanced 3-T Magnetic Resonance Angiography of Pelvic Arteries: Initial Experience	19
A Novel Deep Learning–based Artificial Intelligence System for Interpreting Urolithiasis in Computed Tomography	19
Pushing Fluids: A Case for Liquid Biomarkers Before Imaging in Pre–Prostate Biopsy Decision-making	18
Re: Pawel Rajwa, Takafumi Yanagisawa, Manuel Gruber, et al. Surgical Metastasectomy for Visceral and Bone Prostate Cancer Metastases: A Mini-review. Eur Urol Focus 2023;9:232–5	18
Re: Nicholas Corsi, David-Dan Nguyen, Mohit Butaney, et al. Top 100 Urology Influencers on Twitter: Is Social Media Influence Associated with Academic Impact? Eur Urol Focus. In press. https://doi.org	18
Prostatic Urethral Lift Versus Medical Therapy: Examining the Impact on Sexual Function in Men with Benign Prostatic Hyperplasia	18
Impact of Performance Status on Oncologic Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitor: A Systematic Review and Meta-analysis	18
Clinical Consultation Guide: Pelvic Floor Prehabilitation	17
Impact of a Perioperative Smoking and Alcohol Cessation Intervention on Health-related Quality of Life in Patients Undergoing Radical Cystectomy: A Randomised Controlled Trial	17
Reply to Wei He, Shuxiong Zeng, and Chuanliang Xu’s Letter to the Editor re: Riccardo Mastroianni, Gabriele Tuderti, Mariaconsiglia Ferriero, et al. Robot-assisted Radical Cystectomy with Totally Intr	17
Patient-derived Organoids in Bladder Cancer: Opportunities and Challenges	17
Discovery of Antimicrobial Peptides in Urinary Tract Infections	17
Reply to Kaushik P. Kolanukuduru, Michael Gorin, Ash K. Tewari, and Mani Menon’s Letter to the Editor re: Alec Zhu, Mary O. Strasser, Timothy D. McClure, et al. Comparative Effectiveness of Partial Gl	17
Advances in Retroperitoneal Access for Robotic Surgery	17
Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi’s Letter to the Editor re: Francesco Soria, Marco Moschini, David D’Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of	17
Tumor Size Predicts Muscle-invasive and Non–organ-confined Disease in Upper Tract Urothelial Carcinoma at Radical Nephroureterectomy	17
Drug-induced Urinary Retention: An Analysis of a National Spontaneous Adverse Drug Reaction Reporting Database	17
Mini-review: Evaluation and Management of Retroperitoneal Masses in Patients with Testicular Cancer	17
Reply to Shun Wan, Kun-peng Li, and Li Yang’s Letter to the Editor re: Jordan M. Rich, Kennedy E. Okhawere, Charles Nguyen, et al. Transperitoneal Versus Retroperitoneal Single-port Robotic-assisted P	17
Best Practice in Interventional Management of Urolithiasis: An Update from the European Association of Urology Guidelines Panel for Urolithiasis 2022	17
Reuse and Reprocessing of Endoscopic Instruments: For	17
What Is a Variant of Uncertain Significance in Genetic Testing?	17
Impact of Robotic Artificial Urinary Sphincter Implantation in Female Patients on Quality of Life and Patient-reported Outcomes	16
Long-term Oncological Outcomes for Patients with Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin (BCG): A Comparative Analysis of Adequate Versus Inadequate BCG Treatment	16
The Association of Obstructive Sleep Apnea with Urological Cancer Incidence and Mortality—A Systematic Review and Meta-analysis	16
Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants	16
Sacral Neuromodulation in Multiple Sclerosis: The NEMISIS Study	16
Minimally Invasive Partial Versus Total Adrenalectomy for the Treatment of Primary Aldosteronism: Results of a Multicenter Series According to the PASO Criteria	16
Systemic Treatments for Metastatic Prostate Cancer in 2024	16
The Europa Uomo Patient Reported Outcome Study 2.0—Prostate Cancer Patient-reported Outcomes to Support Treatment Decision-making	16
Same-day Outpatient Robotic Surgery in Urology	16
Telesurgery: Challenges, Ethical Considerations, and Opportunities in the Robotic Surgery Era	16
A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)	15
Re: Siamak Daneshmand, Michiel S. Van der Heijden, Joseph M. Jacob, et al. TAR-200 for Bacillus Calmette-Guérin–unresponsive High-risk Non–muscle-invasive Bladder Cancer: Results from the Phase IIb Su	15
Impact of Synchronous versus Metachronous Metastasis on Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with First-line Immune Checkpoint Inhibitor–based Combinations	15
Re: Moritz von Büren, Severin Rodler, Isabell Wiesenhütter, et al. Digital Real-world Data Suggest Patient Preference for Tadalafil over Sildenafil in Patients with Erectile Dysfunction. Eur Urol Focu	15

Reply to Francesco Montorsi, Giorgio Gandaglia, Federico Dehò, Elio Mazzone, Armando Stabile, and Alberto Briganti’s Letter to the Editor re: Dries Develtere, Giuseppe Rosiello, Pietro Piazza, et al.	15
Treatment Options and Outcomes for Men with Penile Intraepithelial Neoplasia: A Systematic Review	15
Receipt of Overactive Bladder Drugs and Incident Dementia: A Population-based Case-control Study	15
Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysis	15
Reply to Francesco Montorsi, Armando Stabile, Giorgio Gandaglia, and Alberto Briganti’s Letter to the Editor re: K.R. Seetharam Bhat, Marcio Covas Moschovas, Marco Sandri, et al. Outcomes of Salvage R	15
Congenital Lower Urinary Tract Obstruction: Update and Summary of the European Association of Urology and European Society for Paediatric Urology Guidelines	15
Robot-assisted Radical Prostatectomy with the Hugo RAS and da Vinci Surgical Robotic Systems: A Systematic Review and Meta-analysis of Comparative Studies	15
The Use of Three-dimensional Visualization Techniques for Prostate Procedures: A Systematic Review	15
Silodosin for Prevention of Ureteral Injuries Resulting from Insertion of a Ureteral Access Sheath: A Randomized Controlled Trial	15
Re: Yash S. Khandwala, Simon John Christoph Soerensen, Shravan Morisetty, et al. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prost	15
Bladder Chemoprophylaxis Following Ureterorenoscopy in Patients with Upper Tract Urothelial Carcinoma	15
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging of Selected Renal Tumours: Initial Experience in a Multicentre Cohort	14
Associations of PTEN and ERG with Magnetic Resonance Imaging Visibility and Assessment of Non–organ-confined Pathology and Biochemical Recurrence After Radical Prostatectomy	14
New Drugs for Targeted Radionuclide Therapy in Metastatic Prostate Cancer	14
Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate	14
Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality–free Survival in Surgically Treated Papillary Renal Cell Carcinoma Patients	14
Evidence-based Urology: Trustworthy Guidelines	14
European Association of Urology Section of Urolithiasis and International Alliance of Urolithiasis Joint Consensus on Retrograde Intrarenal Surgery for the Management of Renal Stones	14
Risk Prediction Models for Kidney Cancer: A Systematic Review	14
Retroperitoneal Lymph Node Dissection in Patients with Stage II Seminomatous Germ Cell Tumour	14
How Can We Understand Patients’ Values, Preferences, and Expectations in Urology?	14
Immune-based Combinations in Intermediate-/Poor-risk Patients with Non–clear Cell Renal Cell Carcinoma: Results from the ARON-1 Study	14
Better Oncological Outcomes After Prostate-specific Membrane Antigen Positron Emission Tomography–guided Salvage Radiotherapy Following Prostatectomy	14
Fixed-effect Versus Random-effects Models for Meta-analyses: Random-effects Models	14
Quality Indicators in the Clinical Specialty of Urology: A Systematic Review	14
From Avoiding Overtreatment and Undertreatment to Delivering the Right Therapy at the Right Time for the Right Tumor in the Right Patient: The Age of the Thoughtful Urologic Oncologic Surgeon Has Begu	14
Pilot Study: Next-generation Sequencing of the Semen Microbiome in Vasectomized Versus Nonvasectomized Men	14
Comparison of Patient-reported Health-related Quality of Life Between Open Radical Cystectomy and Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Interim Analysis of a Randomi	13
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery Guidelines	13
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: An Updated Network Meta-analysis Including ARANOTE Data	13
Genomic Sequencing Should Be Part of the Standard of Care for Most Urologic Cancers: For	13
Re: Alec Zhu, Mary O. Strasser, Timothy D. McClure, et al. Comparative Effectiveness of Partial Gland Cryoablation Versus Robotic Radical Prostatectomy for Cancer Control. Eur Urol Focus 2024;10:843–5	13
Reply to Kun-Peng Li, Shun Wan, Chen-Yang Wang, and Li Yang’s Letter to the Editor re: Tatsushi Kawada, Ekaterina Laukhtina, Fahad Quhal, et al. Oncologic and Safety Outcomes for Endoscopic Surgery Ve	13
Management of Erythrocytosis in Men Receiving Testosterone Therapy: Clinical Consultation Guide	13
Thermal Partial Prostate Ablation for Intermediate- and High-risk Prostate Cancer: Con	13
Evaluating the Certainty of Evidence in Evidence-based Medicine	13
Evidence-based Urology: Subgroup Analysis in Randomized Controlled Trials	13
Efficacy and Safety of Eliapixant in Overactive Bladder: The 12-Week, Randomised, Placebo-controlled Phase 2a OVADER Study	13
Emerging Technologies for the Surgical Management of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Obstruction. A Systematic Review	13
Editorial Board	13
Does Testicular Sperm Improve Intracytoplasmic Sperm Injection Outcomes for Nonazoospermic Infertile Men with Elevated Sperm DNA Fragmentation? A Systematic Review and Meta-analysis	13
In Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy, Dynamics of Circulating Tumor DNA Following Cystectomy: Association with Patient Outcomes	13
PARP Inhibitor Addition to Androgen Receptor Pathway Inhibitors in Metastatic Castration-resistant Prostate Cancer Should Be Limited to BRCA Mutation Carriers	13
Medium-term Oncological Efficacy and Patient-reported Outcomes After Focal High-intensity Focused Ultrasound: The FOXPRO Trial	13
Oncologic and Safety Outcomes for Endoscopic Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An Updated Systematic Review and Meta-analysis	13
Long-term Follow-up of Intravesical Onabotulinum Toxin-A Injections in Male Patients with Idiopathic Overactive Bladder: Comparing Surgery-naïve Patients and Patients After Prostate Surgery	13
Prostate Cancer Survivorship Today: Support that Spans the Journey	13
Discovery of a Recurrent Frameshift Ashkenazi Jewish Founder Mutation (F722fs) in the PARP Inhibitor–sensitive MMS22L Gene Associated with Higher Risk of Prostate Cancer	13
Reply to Bernardo Rocco and Maria Chiara Sighinolfi’s Letter to the Editor re: Romain Diamand, Jean-Baptiste Roche, Elena Lievore, et al. External Validation of Models for Prediction of Side-specific	13
Differences in Quality of Life between German and Dutch Patients with Prostate Cancer Treated with Robot-assisted Radical Prostatectomy: Implications for International Multicenter Randomized Controlle	13
Reply to Laila Schneidewind, Fabian P. Stangl, Jennifer Kranz, and Gernot Bonkat’s Letter to Editor re: Fredrik Liedberg, Evanguelos Xylinas, Paolo Gontero. Quinolone Prophylaxis in Conjunction with B	13
Does Endoscopic Enucleation of the Prostate Need New Lasers? Current Perspective on New Laser Devices	12
STARLITE 1: Phase 1b/2 Study of Combined 177Lu-Girentuximab plus Cabozantinib and Nivolumab in Treatment-naïve Patients with Advanced Clear-cell Renal Cell Carcinoma	12
Suprapubic Transvesical Adenoma Resection of the Prostate (STAR-P): A Novel Technique for Surgical Treatment of Benign Prostatic Hyperplasia	12
Characterization of Changes in Penile Microbiome Following Pediatric Circumcision	12
A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance	12
Urinary Stones and Intervention Quality of Life (USIQoL): Development and Validation of a New Core Universal Patient-reported Outcome Measure for Urinary Calculi	12
Local Treatment (Primary Tumor and Metastases) in Metastatic Prostate Cancer	12
Long-term Cancer Control Outcomes After Robot-assisted Radical Prostatectomy in Pathologically Non–organ-confined High-risk Prostate Cancer: 20-year Report from a Single Tertiary Referral Center	12
Surgical Management of Synchronous, Bilateral Renal Masses: A 1-decade Referral Center Experience	12
Re: Philipp Mandel, Benedikt Hoeh, Mike Wenzel, et al. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis. Eur Urol Focu	12
Salvage Radical Prostatectomy for Recurrent Prostate Cancer After Primary Nonsurgical Treatment: An Updated Systematic Review	12
Readability Assessment of Patient Education Materials on Uro-oncological Diseases Using Automated Measures	12
Artificial Intelligence–based Detection of FGFR3 Mutational Status Directly from Routine Histology in Bladder Cancer: A Possible Preselection for Molecular Testing?	12
Choosing the Most Efficacious and Safe Oral Treatment for Idiopathic Overactive Bladder: A Systematic Review and Network Meta-analysis	12
Influence of Kidney Environment Parameters on Antibiotic Efficacy Against Uropathogenic Escherichia coli	12
Initial Experience and Evaluation of a Nomogram for Outcome Prediction in Management of Medium-sized (1–2 cm) Kidney Stones	12
Development and Validation of a Deep Learning System for Sound-based Prediction of Urinary Flow	12
Prostatic Artery Embolization in Patients with Prostate Cancer: A Systematic Review	12
Outcomes of Grade Group 2 and 3 Prostate Cancer on Initial Versus Confirmatory Biopsy: Implications for Active Surveillance	12
Ureteral Obstruction Promotes Ureteral Inflammation and Fibrosis	11
Evidence-based Urology: Introduction to Our Series of Articles	11
European Association of Urology Guidelines on Urethral Stricture Disease Part 3: Management of Strictures in Females and Transgender Patients	11
Biophotonics—Intraoperative Guidance During Partial Nephrectomy: A Systematic Review and Meta-analysis	11
European Association of Urology Guidelines on Penile Size Abnormalities and Dysmorphophobia: Summary of the 2023 Guidelines	11
Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639–41	11
Hypothesis: Disrupted Regulation of the Intracranial Vascular and Cerebrospinal Fluid Circulations Causes Nocturia	11
Contents	11
A Restaging Transurethral Resection of Bladder Tumor Is Always Necessary For High-grade T1 Non–muscle-invasive Bladder Cancer	11
Effect of a Smoking and Alcohol Cessation Intervention Initiated Shortly Before Radical Cystectomy—the STOP-OP Study: A Randomised Clinical Trial	11
Robot-assisted Radical Prostatectomy Performed with Different Robotic Platforms: First Comparative Evidence Between Da Vinci and HUGO Robot-assisted Surgery Robots	11
Reply to Francesco Montorsi, Edoardo Pozzi, Marco Bianchi, et al’s Letter to the Editor re: Gautier Müllhaupt, Lukas Hechelhammer, Nicole Graf, et al. Prostatic Artery Embolisation Versus Transurethra	11
Comparison of Bacillus Calmette-Guérin Maintenance Therapy with Monthly Instillations and the Southwest Oncology Group Protocol in the Treatment of Non–muscle-invasive Bladder Cancer	11
Re: Tarek Benzouak, Abdulmalik Addar, Michael A. Prudencio-Brunello, et al. Comparative Analysis of Holmium Laser Enucleation of the Prostate (HoLEP) and Robotic-Assisted Simple Prostatectomy (RASP) i	11
Lower Detrusor Apron–sparing Robot-assisted Radical Cystectomy and Intracorporeal Neobladder Reconstruction: Technique and Preliminary Outcomes	11
Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression	11
Optimizing Lymph Node Dissection at the Time of Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma	11
Mirabegron for the Treatment of Ureteral Stent-related Symptoms: A Systematic Review and Meta-analysis	11
Survival Outcomes and Recurrence Patterns Following Focal High-intensity Focused Ultrasound Treatment for Localized Prostate Cancer: Insights on Patient Selection and Lessons Learned	11
Targeted Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy for Quantitative Gleason 4 Grading Prediction in Radical Prostatectomy Specimens: Implications for Active Surveillance Cand	11
Improving Guideline Adherence in Urology	11
Assessment and Treatment of Nocturia in Endocrine Disease in a Primary Care Setting: Systematic Review and Nominal Group Technique Consensus	11
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer	10
Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomi	10
Results of Stress Incontinence Surgery in Octogenarian Women	10